In the early days of Columbia's cancer program, these incredible women physicians and scientists made key discoveries in the field of cancer research and medicine.
As one of the early pioneers of surgical pathology, Dr. Frantz made a series of important cancer discoveries, including key studies of the surgical pathology of insulin-secreting pancreatic tumors.
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
A distinguished leader in surgery, medicine, and academia, Dr. Forde applied a strong but gentle approach to enacting change during his longstanding career.
In a new study, researchers demonstrate that applying artificial intelligence to standard-of-care imaging can help predict how well immunotherapy will work for patients with melanoma.
Carmela Brunelli has remained in remission after completing a trial that offers a promising, entirely new bladder-saving treatment option for patients.
The Trainee Associate Member Pilot Grants Program aims to support up-and-coming graduate and medical student and post-graduate researchers across Columbia working on all aspects of cancer research.
A new grant from the National Institute of Health will establish a multi-institutional group in New York City to address health disparities in multiple chronic diseases.
